Rooftops and billboards may be more important than hefty infrastructure.
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Goldman says these top tech stocks have plenty of upside ahead of earnings
Goldman Sachs said this week there are plenty of top tech companies to buy heading into their quarterly results.
Apple is set to take back the market-cap crown from Nvidia. Upcoming earnings may push it over the top
Apple stock is trading near record highs and closing in on Nvidia’s market cap. Portfolio manager Jeff Kilburg explains what’s driving the rally and why he thinks the momentum could continue.
Kinder Morgan, Energy Transfer and Williams could benefit from cheap natural gas
Pipeline operators are in a sweet spot as natural gas stays cheap and plentiful, stoking demand.
The S&P 500 is forming a bearish chart pattern. Can it snap out of it?
The S&P 500 has struggled to break decisively above 7,800 since first reaching that area in late July.
I warned against buying this AI chip stock. Now I think it could nearly double
Cerebras has lost roughly 72% of its value since its peak, but contrarian tech investor Paul Meeks says its AI technology and massive backlog could fuel a comeback.
Why investors are moving back into Treasurys
U.S. Treasurys are returning to favor as a safe haven play that sidesteps investors’ worries over a shaky economy and the future of the data center build-out.
SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
PhillipCapital moved its rating on the Elon Musk giant to buy from sell, with the bullishness stemming from the company’s AI business.
Friday’s big stock stories: What’s likely to move the market in the next trading session
The Nasdaq Composite dropped 2.6% on Thursday as worries over spending on artificial intelligence ramped up.